Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
28,495,649
Total 13F shares
810,171
Share change
-15,765
Total reported value
$2,373,801
Price per share
$2.93
Number of holders
2
Value change
-$46,191
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2024

As of 31 Mar 2024, Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 810,171 shares. The largest 2 holders included AWM Investment Company, Inc. and Defender Capital, LLC.. This page lists 2 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.